AQR Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,030,748
| Closed | -$11.5M | – | 2327 |
|
|
2017
Q3 | $11.5M | Buy |
1,030,748
+148,852
| +17% | +$1.67M | 0.01% | 731 |
|
|
2017
Q2 | $9.7M | Buy |
881,896
+22,848
| +3% | +$251K | 0.01% | 782 |
|
|
2017
Q1 | $8.42M | Buy |
859,048
+22,239
| +3% | +$218K | 0.01% | 820 |
|
|
2016
Q4 | $9.04M | Sell |
836,809
-42,058
| -5% | -$454K | 0.01% | 796 |
|
|
2016
Q3 | $9.01M | Buy |
878,867
+317,894
| +57% | +$3.26M | 0.01% | 801 |
|
|
2016
Q2 | $7.33M | Sell |
560,973
-140,903
| -20% | -$1.84M | 0.01% | 795 |
|
|
2016
Q1 | $7.72M | Sell |
701,876
-175,200
| -20% | -$1.93M | 0.01% | 746 |
|
|
2015
Q4 | $8.07M | Buy |
877,076
+105,990
| +14% | +$975K | 0.01% | 776 |
|
|
2015
Q3 | $5.35M | Buy |
771,086
+212,235
| +38% | +$1.47M | 0.01% | 798 |
|
|
2015
Q2 | $5.49M | Buy |
558,851
+346,742
| +163% | +$3.41M | 0.01% | 795 |
|
|
2015
Q1 | $1.88M | Buy |
212,109
+168,509
| +386% | +$1.49M | ﹤0.01% | 1136 |
|
|
2014
Q4 | $382K | Buy |
43,600
+29,700
| +214% | +$260K | ﹤0.01% | 2086 |
|
|
2014
Q3 | $96K | Sell |
13,900
-15,380
| -53% | -$106K | ﹤0.01% | 2448 |
|
|
2014
Q2 | $154K | Sell |
29,280
-77,600
| -73% | -$408K | ﹤0.01% | 2413 |
|
|
2014
Q1 | $486K | Sell |
106,880
-121,100
| -53% | -$551K | ﹤0.01% | 2055 |
|
|
2013
Q4 | $1.15M | Sell |
227,980
-136,400
| -37% | -$687K | ﹤0.01% | 1661 |
|
|
2013
Q3 | $1.85M | Sell |
364,380
-411,020
| -53% | -$2.08M | 0.01% | 1333 |
|
|
2013
Q2 | $3.85M | Buy |
+775,400
| New | +$3.85M | 0.01% | 971 |
|